You likely know about the use of Methotrexate in treating conditions such as rheumatoid arthritis and Crohn’s disease – but did you know it is also used to treat psoriasis and psoriatic arthritis (PsA)?
The Psoriasis Association is pleased to share an updated version of its popular information sheet about Methotrexate, produced as part of an ongoing commitment to providing reliable, good quality health information. Methotrexate is often used on its own to treat psoriasis or psoriatic arthritis, however it is sometimes used in conjunction with other medications, such as biologics, in order to help the other medication work more effectively by preventing the body from building up antibodies.…
Read more of this article
The Royal College of Chiropractors’ Quality Standards are tools designed to help deliver the best possible outcomes for patients. They are a series of specific, concise quality statements with associated measures that provide aspirational, but achievable, markers of high-quality patient care covering the treatment of different conditions. They also form an important part in the process of improving quality and patient outcomes.
The report is a collection of the most up-to-date, UK-wide statistics on arthritis and other musculoskeletal (MSK) conditions. It is a resource for healthcare professionals, policy makers, public heath leads, researchers, people with these conditions, and anyone interested in MSK health. Arthritis UK believes that with the best information you can build awareness, make more informed decisions, feel more confident and ultimately help more people with MSK conditions, such as arthritis.
ROS and APPG on Osteoporosis and Bone Health Inquiry Report on Access to Medicines
GIRFT is getting started on a £3.5m programme of activity working with 17 ICBs with the highest waiting lists for elective community MSK services.
The National Early Inflammatory Arthritis Audit (NEIAA) State of the Nation Summary Report 2024 was published on 10 October 2024.